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Highlights 
 The ratio and absolute number of circulating TFH-like cells were assessed in AD  
 ICOS+ TFH-like cell ratios and numbers were increased mainly in children with AD 
 IL-21+ TFH-like cell percentages were elevated in children compared to adults in AD  
 SCORAD index correlated with the numbers of IL-21+ TFH-like cells in paediatric AD 
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Abstract 
Follicular helper T (TFH) cells play crucial role in B-cell differentiation and antibody 
production. Although, atopic dermatitis (AD) is often associated with increased serum 
IgE levels, B-cell mediated responses have not been studied thoroughly. The aim of our 
study was to investigate the proportion of TFH-like cells in the disease. Twelve children 
and 17 adults with AD as well as 14 healthy controls were enrolled in the study. The 
frequency of CD4+CXCR5+ICOS+PD-1+ TFH-like cells and their IL-21 cytokine 
production were determined by flow cytometry. Immunohistochemical analysis was 
performed on skin biopsy specimens from AD patients for the detection of TFH markers. 
The percentages and absolute numbers of circulating TFH-like cells were significantly 
increased in children with AD compared to adult patients and healthy controls. IL-21 
cytokine production of TFH-like cells was also elevated and showed a strong positive 
correlation with paediatric patients’ SCORAD index. The expression of TFH-specific 
markers showed only a non-specific scattered pattern in skin biopsy specimens. This is 
the first study to demonstrate that TFH-like cells expanded in the peripheral blood of 
children with AD compared to adults. These results reinforce the importance of further 
investigations on TFH-like cells in different phenotypes and endotypes of AD. 
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Abbreviations 
AD: atopic dermatitis  
CSR: class-switch recombination  
CXCR5: chemokine (C-X-C motif) receptor type 5  
DCs: dendritic cells  
DEHP: di-(2-ethylhexyl)phthalate  
FFPE: formalin-fixed, paraffin-embedded  
GC: germinal center  
ICOS: inducible T cell co-stimulator  
Ig: immunoglobulin  
IL: interleukin  
PD-1: programmed cell death protein 1  
PerCP-Cy5.5: Peridinin-chlorophyll protein-Cyanine dye 5.5 
PMA: phorbol-12-myristate 13-acetate  
SAP: signalling lymphocytic activation molecule (SLAM)-associated protein  
SCORAD: SCORing Atopic Dermatitis 
SHM: somatic hypermutation  
STAT3: signal transducer and activator of transcription 3  
TFH: Follicular helper T  
Th: T helper 
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1. Introduction  
Atopic dermatitis (AD) is a chronic inflammatory skin disease. Clinically, it results in 
itchy, hyperaemic, swollen, excoriated plaques, which may also show lichenification. In 
about 80 % of patients, the disease associates with elevated levels of serum 
immunoglobulin (Ig) E [1]. The prevalence of the disease has strongly increased in 
developed countries during the last few years. According to epidemiological studies, it 
affects approximately 2-10 % of the adult and 15-30 % of the paediatric population 
worldwide [2]. Genetic predisposition as well as environmental factors exerts a profound 
influence on the disruption of intact epidermal barrier and on the development of 
abnormal immune responses. The interaction of above mentioned elements contribute to 
the sensitization and the development of unique clinical features of the disease [3, 4]. AD 
is known to be a complex heterogeneous disease with various phenotypes and endotypes 
which arises from age-related differences, acute or chronic phase of the disease and the 
presence or absence of allergen sensitizations may be associated with distinct branches 
of immune activation [5]. The pathomechanism of AD may be easier to understood as a 
biphasic system with the predominance of T helper (Th) 2 mediated responses with 
elevated interleukin (IL)-4 and IL-13 cytokines and Th22 cells in the acute phase followed 
by an expanded Th1 and Th17 guided responses in the chronic period [4, 6, 7]. Despite 
the complex interactions between keratinocytes, skin dendritic cells (DCs) and T cells, 
for the most part, generalized Th2 dysbalance and isotype switching of B cells to generate 
specific IgE is often associated with AD. However, the role of B cells and other 
participants in the regulation of humoral immunity in allergic or skin diseases has 
remained poorly examined. Although studies about the expansion of circulating B cells 
in patients with psoriasis and AD are reported, observations regarding B cell mediated 
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immune responses are limited [8, 9]. For that purpose, the profound examination of 
germinal center (GC) processes with a special emphasis on the regulation of IgE-
producing plasma cell generation needs to be clarified in AD. 
Follicular helper T (TFH) cell, a specialized subset of CD4
+ T cells provides fundamental 
help to antigen specific B-cells in proliferation, differentiation as well as antibody 
production, are one of the most intensively studied cells [10, 11]. In the past few years, 
numerous research groups have described altered ratio of circulating TFH-like cells in 
autoimmune and inflammatory diseases. Expansion of CD4+CXCR5+ TFH-like cells was 
reported in autoimmune diseases, including systemic lupus erythematosus [12, 13], 
Sjögren’s syndrome [14, 15], rheumatoid arthritis [16], juvenile dermatomyositis [17] and 
bullous pemphigoid [18]. However, in dermatology, investigations of TFH-like cells are 
limited and occur mostly in cutaneous lymphomas [19] or inflammatory disorders such 
as psoriasis [20-22]. TFH cells arise from activated T cells following the encounter with 
DCs, and migrate to the border of T and B cell areas in the lymph node under the guidance 
of Bcl-6 or c-Maf mediated chemokine receptors [23, 24]. GC localized TFH cells are 
distinguished from other effector T cells by the intense expression of chemokine (C-X-C 
motif) receptor type 5 (CXCR5), inducible T cell co-stimulator (ICOS), programmed cell 
death protein 1 (PD-1) and the production of IL-21. Additional features include the 
elevated expression of CD40L, OX40L, signalling lymphocytic activation molecule 
(SLAM)-associated protein (SAP) and SLAM family receptors such as CD84 [25-27]. 
The interplay between TFH and activated B cells is essential not only for GC reactions, 
including somatic hypermutation (SHM) and immunoglobulin class-switch 
recombination (CSR), but for the generation of extrafollicular responses as well [28].  
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The special capability of TFH cells to direct B cell responses and antibody production 
proposed the possibility that they may play an important role in the pathogenesis of AD. 
Based on that potential concept, we investigated the distribution of TFH cells and their 
markers not only in the peripheral blood, but in skin biopsy samples of patients with AD 
as well. 
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2. Material and methods 
2.1.  Patients and healthy individuals 
Peripheral blood was obtained from 29 patients with AD (19 female and 10 male; mean 
age 18.97 ± 11.03 years) for flow cytometric analysis. Fourteen healthy individuals (11 
female and 3 male; mean age 22.64 ± 10.16 years) served as controls. Among control 
subjects, there were 4 individuals under 16 years (3 female and 1 male; mean age 8.50 ± 
4.80 years). Since their cell ratios did not differ significantly, we included them into one 
control pool. AD patients were classified based on their age: one group comprised 
subjects with 12 children (10 female and 2 male; mean age 9.58 ± 3.82), while the other 
group consisted of subjects with 17 adults (9 female and 8 male; mean age 26.58 ± 7.99). 
Skin biopsy specimens were also collected from 5 patients at the Department of 
Dermatology, Clinical Center, University of Debrecen. All patients fulfilled the 
diagnostic criteria for AD established by Hanifin and Rajka [29]. The severity of the 
disease was determined by the SCORAD (SCORing Atopic Dermatitis) index. The mean 
SCORAD index of the patients was 43.21 ± 13.04 with the range of 24-72. In children, 
the mean SCORAD index was 43.67 ± 11.91 with the range of 28-68, while in adult it 
was 42.88 ± 13.82 with the range of 24-72. The median serum total IgE was 1453 kU/L 
with a range of 22-10000 kU/L. The titer of IgE was 637 kU/L (22-10000 kU/L) in 
children and 2537 kU/L (135-10000 kU/L) in adults. None of the patients received any 
antihistamines or topical corticosteroids for at least 5 days, or systemic 
immunosuppressive or immunomodulating medications for at least 4 weeks prior to the 
collection of blood samples. No patients or controls had ongoing or recent previous 
infections during the study. Data were obtained retrospectively from patients’ records 
which contained detailed information about other possible allergic disease and 
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sensitization. Informed written consent was obtained from the subjects, and the study was 
approved by the Ethics Committee of the University of Debrecen. All experiments carried 
out were in compliance with the Declaration of Helsinki. Demographic data were 
summarized in Table 1. 
 
2.2.  Determination of circulating TFH-like cells by flow cytometry 
For the assessment of circulating TFH cells, cells from 100 μl of heparinized whole 
peripheral blood were stained with CXCR5-Alexa Fluor 488 (clone: RF8B2)/ICOS-PE 
(clone: DX29)/PD-1-Peridinin-chlorophyll protein-Cyanine dye 5.5 (PerCP-Cy5.5) 
(clone: EH12.1)/CD4-APC (clone: RPA-T4) (all from BD Biosciences, San Jose, CA, 
USA) fluorochrome-labeled monoclonal antibodies. After the incubation period, 
erythrocytes were haemolysed. Stained cells were assessed using a FACS Calibur flow 
cytometer (Becton Dickinson, Franklin Lakes, NJ, USA) and data analysis was performed 
by FlowJo Software (Treestar, Ashland, OR, USA). At least 40.000 CD4+ events of each 
sample were analysed within the entire lymphocyte population. The absolute number of 
TFH-like cells was determined from the percentage of these cells calculated by flow 
cytometry and from the absolute number of lymphocytes (x 109 L-1) detected by a 
haematological cell counter. 
 
2.3.  Determination of single-cell cytokine production of circulating TFH-like cells by 
intracellular cytokine analysis 
For intracellular cytokine examination, diluted whole blood was incubated with phorbol-
12-myristate 13-acetate (PMA) (25 ng/ml), ionomycin (1 μg/ml), and Golgi Stop 
brefeldin-A (10 μg/ml) (all from Sigma Aldrich, St Louis, MO, USA) at 37°C in 5% CO2 
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milieu for 5 h. Cell surface staining was performed with fluorochrome-labeled 
monoclonal antibodies against CD4, CXCR5, PD-1 for 15 minutes at room temperature. 
Cells were then fixed and after erythrocyte lysation the membrane of the lymphocytes 
was permeabilized with IntraprepTM permeabilization reagent (Beckman Coulter Inc, 
Miami, FL, USA) according to the manufacturer's instructions. Cytokines were stained 
with anti-IL-4-PE, anti-IL-10-PE and anti-IL-21-PE (all from BD Biosciences) for 30 
minutes at room temperature. Measurements were performed and data were collected 
using a FACS Calibur flow cytometer (Becton Dickinson, Franklin Lakes, NJ, USA) and 
data were analyzed using FlowJo Software (Treestar, Ashland, OR, USA). In case of 
intracellular measurements at least 20.000 CD4+ events per sample were analysed within 
the whole lymphocyte population. 
 
2.4.  Immunohistochemistry  
Immunostainings were performed on formalin-fixed, paraffin-embedded (FFPE) tissue 
blocks on lesional skin from AD patients’ forearm (all severe AD; n=5). Four-μm thick 
serial sections of tissue specimens were prepared and stained with haematoxylin-eosin 
for conventional histopathological examination. Additional 4 μm thick FFPE sections 
were deparaffinized, rehydrated on descending ethanol dilutions and treated with H2O2 to 
block endogenous peroxidase. For antigen retrieval, sections were heated in boiling 
citrate buffer (pH 6.0) or Tris/EDTA buffer (pH 9.0) using a pressure cooker. After 
cooling, the slides were incubated with primary antibodies for 1 hour at room temperature 
or overnight at 4°C. The following antibodies were used in the procedure: mouse 
monoclonal anti-CD20 (clone L26, Dako, Glostrup, Denmark); rabbit monoclonal anti-
CD84 (clone EPR8325, Abcam, Cambridge, UK); rabbit polyclonal anti-PD-1 (bs-
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1867R, Bioss, Woburn, MA, USA); rabbit polyclonal anti-Bcl6/5 (bs-2734R, Bioss), 
rabbit polyclonal anti-IL-21 (Abcam). Super Sensitive One-Step Polymer-HRP Detection 
System (BioGenex, Fremont, CA, USA) as secondary antibody with Very Intense Purple 
peroxidase substrate (Vector Laboratories, Peterborough, UK) were used for detection. 
The sections were then counterstained with methyl green (Vector Laboratories). Images 
of skin tissue sections were taken using a Leica DM2000 LED (Leica Microsystems 
GmbH, Wetzlar, Germany) microscope equipped with an Evolution™ MP 5.0 Mega-
pixel Camera Kit (Media Cybernetics, Inc., Silver Spring, MD USA) connected to a 
computer. For transferring and editing images, QCapture Pro 6 (QImaging, Surrey, BC 
Canada) and Adobe Photoshop CS5 were used. 
 
2.5.  Statistical analysis 
Data were analyzed and statistically evaluated with GraphPad Prism 5 software 
(Graphpad Software, San Diego, USA). To assess the distribution of the data 
Kolmogorov-Smirnov test was used. In cases of normal distribution, if the F probe was 
granted we used unpaired two-sample t test, otherwise if it was not granted, we used 
Welch’s t test for statistical comparison of the experimental data. In cases if distributions 
the data set was different from normal, the Mann–Whitney U test was used. The 
correlations between two variables were evaluated with Pearson’s rank correlation 
coefficient. Differences were considered statistically significant at p<0.05.  
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3. Results 
3.1. Expression of TFH-related cell specific markers on CD4+CXCR5+ T cells 
According to the expression of CXCR5, we gated a CD4+CXCR5+ lymphocyte subgroup 
and determined the fractions of ICOS+, PD-1+ and ICOS+PD-1+ T cells in children as well 
as adults with AD versus healthy controls (Fig. 1A). The ratio of ICOS+ cell among 
CD4+CXCR5+ lymphocytes were significantly increased in children with AD when 
compared to adults with AD and healthy controls (15.66 ± 7.723% vs. 7.618 ± 4.149%, 
respectively, p=0.0050 and 15.66 ± 7.723% vs. 7.616 ± 4.515%, respectively, p=0.0030) 
(Fig. 1A). The percentages of PD-1+ cells were also significantly elevated in children with 
AD, compared to adults with AD and increased in healthy individuals as well (38.88 ± 
6.568% vs. 28.18 ± 6.673%, respectively, p=0.0047 and 35.88 ± 6.568% vs. 30.72 ± 
7.730%, respectively, p=0.0818) (Fig. 1A). We obtained the same tendency when 
analyzed ICOS+PD-1+ cell percentages, the ratio of double positive cells showed a 
significant expansion in children with AD in contrast to adults with AD and controls 
(9.539 ± 4.940% vs. 4.521 ± 2.648%, respectively, p=0.0059 and 9.539 ± 4.940% vs. 
4.315 ± 2.430%, respectively, p=0.0044) (Fig. 1A). We did not find significant difference 
in the ratio of the aforementioned markers between adults with AD and control group; 
interestingly, the proportions of ICOS and PD-1 differed barely from control values. 
To measure the nature and frequency of circulating CD4+CXCR5+ T cell subset, the de 
novo synthesized intracellular IL-21 cytokine production was also determined (Fig. 1B). 
Similarly to cell surface staining, the frequency of PD-1+ cells were showed the same 
tendency and significantly elevated in children with AD compared those measured in 
adults with AD and controls (34.80 ± 7.149% vs. 26.91 ± 7.075%, respectively, p=0.0207 
and 33.49 ± 7.149% vs. 26.61 ± 6.721%, respectively, p=0.0185) (Fig. 1B). The ratio of 
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CD4+CXCR5+ T cells producing IL-21 was increased in children with AD, however it 
did not differ significantly compared to adults with AD and controls (Fig. 1B). The 
frequency of PD-1+IL-21+ cells were non-significantly increased in children with AD 
compared to healthy controls (9.807 ± 3.732% vs. 7.104 ± 4.140%, respectively, 
p=0.0525) (Fig. 1B). These cell proportions also differed between children and adults 
with AD (9.807 ± 3.732% vs. 7.412 ± 2.913%, respectively, p=0.0628), but it was not 
significant (Fig. 1B).   
 
3.2. Quantification of circulating TFH-like cells 
Circulating TFH-like cells were quantified as their percentages within the CD4
+ 
lymphocytes of peripheral blood. According to our results, the percentages of 
CD4+CXCR5+ICOS+ T cells were significantly increased in children with AD when 
compared to adults with AD and healthy controls (1.675 ± 0.8029% vs. 0.8860 ± 
0.5281%, respectively, p=0.0035 and 1.675 ± 0.8029% vs. 0.9991 ± 0.6141%, 
respectively, p=0.0230) (Fig. 2A). Cell ratios in the group of adults with AD did not differ 
from control values. The proportions of CD4+CXCR5+PD-1+ T cells were significantly 
decreased in adults with AD, compared to control results (3.203 ± 1.095% vs. 4.138 ± 
1.356%, respectively, p=0.0422) (Fig. 2A). Although cell ratios were lower in children 
with AD than in healthy individuals, it did not differ significantly. The same tendency 
was observed between children and adults with AD. The percentages of 
CD4+CXCR5+ICOS+PD-1+ TFH-like cells were significantly increased in children with 
AD compared those quantified in adults with AD and controls (1.019 ± 0.4977% vs. 
0.5196 ± 0.3253%, respectively, p=0.0029 and 1.019 ± 0.4977% vs. 0.5680 ± 0.3360%, 
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respectively, p=0.0113) (Fig. 2A). The ratio of TFH-like cells was similar in adults with 
AD and healthy individuals. 
In order to gain a better view on the distribution of TFH-like cells in the peripheral blood 
of AD patients and controls, we quantified the absolute numbers of the investigated cell 
populations. Significantly elevated absolute numbers of CD4+CXCR5+ICOS+ T cells 
were found in children with AD in comparison with adults with AD and controls (16.57 
± 8.215 x 106 L-1 vs. 7.159 ± 3.809 x 106 L-1, respectively, p=0.0024 and 16.57 ± 8.215 x 
106 L-1 vs. 10.13 ± 6.081 x 106 L-1, respectively, p=0.0460) (Fig. 2B). Similarly, to cell 
ratios, the absolute numbers of this cell subset in adults with AD did not differ from values 
in control group. The absolute numbers of CD4+CXCR5+PD-1+ T cells were slightly 
increased in children with AD compared to controls; however, the difference was not 
significant. On the other hand, the absolute numbers of these cells in adults with AD were 
significantly dampened in contrast to values measured in children with AD (26.70 ± 6.694 
x 106 L-1 vs. 38.85 ± 14.40 x 106 L-1, respectively, p=0.0165), moreover we found an 
intense significant decrease, when compared to results of control subjects (26.70 ± 6.694 
x 106 L-1 vs. 40.68 ± 14.33x 106 L-1, respectively, p=0.0098) (Fig. 2B). The absolute 
numbers of CD4+CXCR5+ICOS+PD-1+ TFH-like cells were also elevated significantly in 
children with AD, compared to values of adults with AD and controls (10.22 ± 5.248 x 
106 L-1 vs. 4.158 ± 2.215 x 106 L-1, respectively, p=0.0023 and 10.22 ± 5.248 x 106 L-1 
vs. 5.790 ± 3.670 x 106 L-1, respectively, p=0.0302) (Fig. 2B). We did not found any 
difference in the cell count between adults with AD and controls. 
 
3.3. Measurement of individual cytokine production of circulating TFH-like cells 
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To confirm the cytokine profile of circulating TFH-like cells, we assessed the intracellular 
IL-21 cytokine production beside PD-1 expression on CD4+CXCR5+ TFH-like cells. 
Although the ratio of CD4+CXCR5+PD-1+ T cells, CD4+CXCR5+IL-21+ T cells and IL-
21 producing TFH-like cells did not differ significantly in the measured subgroups with 
AD and controls (Fig. 3A). Interestingly, when we quantified the cell subsets between 
children and adults with AD, we revealed that the absolute numbers of both 
CD4+CXCR5+PD-1+ T cells (32.73 ± 10.55 x 106 L-1 vs. 22.61 ± 5.896 x 106 L-1, 
respectively, p=0.0088) and CD4+CXCR5+IL-21+ T cells (16.53 ± 6.771 x 106 L-1 vs. 
12.31 ± 4.738 x 106 L-1, respectively, p=0.0580) were elevated in children in comparison 
with adults, although the latter did not differ significantly (Fig. 3B). On the other hand, 
the absolute numbers of IL-21 producing TFH-like cells showed a distinct significant 
expansion in children with AD compared those analysed in adults with AD (10.17 ± 4.302 
x 106 L-1 vs. 5.891 ± 2.327x 106 L-1, respectively, p=0.0068), while it was only mildly 
elevated in contrast to control values (Fig. 3B). There were no significant differences in 
intracellular IL-4 and IL-10 positivity between patients and controls. 
 
3.4. Correlation analysis between circulating TFH-like cells and SCORAD score in 
patients with AD 
We investigated the possible associations between the ratio of TFH-like cells and the 
SCORAD values in the two subgroups of patients with AD. We discovered an obvious 
significant positive correlation between the absolute numbers of CD4+CXCR5+PD-1+IL-
21+ TFH-like cells and SCORAD index in children with AD (R=0.6105, respectively, 
p=0.0350), while our observations in adults with AD did not reveal any connection with 
the severity of the clinical symptoms (Fig. 3C). 
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3.5. Localization of TFH-related marker expression in skin biopsies 
Skin samples from patients with AD contained only a few cells expressing TFH-specific 
markers and they displayed a scattered distribution tendentiously in the dermis (Fig. 4). 
We detected some CD20+ B cells in the biopsy specimens, although this population form 
a small proportion of the dermal infiltrates. Interestingly, PD-1 marker was strongly 
expressed in the stratum granulosum. It is possible, that the applied antibody could cross-
react with the ligand of PD-1 (PD-1L) which is expressed on activated keratinocytes. 
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4. Discussion 
AD is a multifactorial, immune mediated inflammatory disease characterized by 
increased inflammatory cell migration to the skin lesions, elevated and abnormal 
production of inflammatory cytokines as well as higher amount of Th2 cells and 
frequently increased IgE level in the periphery [3]. According to the literature, IgE 
responses originate from two sources. Early, low-affinity antibodies produced by short-
lived plasma cells arise from extrafollicular sources, whereas late IgE responses with 
high-affinity antibodies derive from GC reactions [30]. Direct switching to IgE results 
lower affinity IgE antibodies produced by short-lived plasma cells which generally form 
the major part of IgE responses [31]. However, sequential CSR in GCs yields IgEs that 
show hypermutations and affinity maturation which could bind environmental antigens 
with higher affinity [30, 32]. The elevated level of IgE in the serum of patients with AD 
raised a question, whether GC processes and TFH cells are responsible for their production 
and regulation. The possible role of TFH cells in allergic diseases has arisen recently, but 
no papers have been published focusing on the ratio and function of these cells in AD yet 
[33, 34].  
In the last few years, multiple studies specialized to understand the origin and function of 
blood CD4+CXCR5+ T cells. These observations indicated that in contrast to GC TFH 
cells, circulating TFH cells express TFH-related markers at lower intensity, however retain 
functional characteristic to promote B cell differentiation and Ig production [17, 35]. At 
the periphery, TFH-like cells appear to represent a memory CD4
+ T cell subset and 
according to the expression of certain molecules, including ICOS, PD-1, CCR7, CXCR3 
and CCR6, could be subdivided into several subsets [17, 36]. In the present study, we 
assessed the distribution of circulating TFH-like cells, moreover we examined the presence 
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of their markers at the site of the inflammation in patients suffering from AD. 
Interestingly, we found significantly elevated ratio of ICOS+ and PD-1+ and increased 
ratio of IL-21+ cells among the peripheral CD4+CXCR5+ T cell subset only in children 
with AD, while the values of these markers in adults with AD were similar those 
measured in healthy individuals. Next, we analysed not only the proportions of TFH-like 
or IL-21 producing TFH-like cells but the absolute numbers of the cells as well. We 
revealed a significant expansion only in paediatric patients with AD compared mainly to 
adults with AD. Our results are consistent with those recent observations showing that 
the initial pathogenic processes and T cell polarization in AD are different in children and 
adults [5]. However, our current knowledge about the pathogenesis of AD generally 
comes from studies on adult population, although the disease prevalence is higher in 
earlier ages. Early AD is often associated with other allergic diseases, including food 
allergy, allergic bronchial asthma as well as allergic rhinoconjunctivitis and from 
childhood this sequential disease development is called the atopic march [37]. Atopy has 
the aptitude to develop heightened IgE levels since T cell-B cell interactions seem to 
associate with this phase [38]. Most studies investigated immune-competent cells in 
cohort of children as well as adults did not compare the results simultaneously. Recently, 
Czarnowicki et al. compared the activation markers and cytokine production of skin-
homing polarized T cell subsets both in children and adults with AD revealing a marked 
difference between the groups. Higher ICOS expression of CD4+ cells were showed 
among paediatric patients with AD. As a next step, T helper cells were distinguished into 
systemic and skin-homing T cell populations, which revealed that ICOS expression was 
characteristic to non-cutaneous T cell subset [39]. Recently, the same group revealed that 
ICOS activated T cells not only participate in the disease maintenance but also correlate 
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with activated and memory B cells [38]. These results along with our findings underline 
the role of ICOS in regulating T-B cell interaction by augmenting their accumulation in 
draining lymph nodes and their importance in Th2 immunity in the early disease 
phenotype [40]. We also investigated the associations between the absolute numbers of 
IL-21 producing TFH-like cells and the SCORAD scores. Although, no significant 
association was found between serum IgE levels and the severity of skin inflammation, 
nevertheless, the SCORAD index showed a strong positive correlation with the absolute 
numbers of IL-21+ TFH-like cells in children. Of note, clinical features of AD show a 
variable pattern according to the phase of the disease and the ages of the patients. In 
children, AD is characterized mainly by acute inflammatory lesions, whereas adults 
generally express skin thickening with eczematous lesions and lichenifications [41]. Our 
correlation analysis supports the role of IL-21 producing circulating TFH-like cells in the 
participation of disease pathogenesis in paediatric patients. Regarding the effect of IL-21 
in antibody production, former studies revealed that IL-21, IL-4 and CD40L could act 
synergistically to enhance the isotype-switching of IgE in human B cells via signal 
transducer and activator of transcription 3 (STAT3) dependent manner [42, 43]. 
Furthermore, an elevated IL-21 and IL-21R expression in skin biopsy of patients with 
psoriasis or AD was published recently [44, 45]. In addition, latter studies revealed an 
altered B cell distribution in AD with elevated transitional B cells, IgE expressing 
memory B cell subsets and plasmablasts; moreover, an elegant work with ovalbumin-
sensitized CD19-deficient mice shed light on the role of B cells in the pathogenesis of 
AD [9, 46]. In another study, low numbers of non-switched memory B cells were showed 
in paediatric AD compared to adult AD confirming the dominance of T-cell dependent 
mechanisms in early childhood [38]. Aforementioned evidences suggest that upon 
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secondary antigen exposure and activation in inflammatory environment, circulating 
memory TFH cells could migrate to draining lymphoid nodes and gain fully matured 
effector TFH phenotype to support GC responses [47, 48]. Additionally, concerning their 
potential plasticity and the current status of the immune system, as highlighted recently, 
they may promote Th2 immunity or gain the characteristics of Th2 cells at the periphery 
[49-51].  
Considering the dermal infiltration of T cells in AD, we examined biopsy samples from 
lesional skin biopsies of patients for the potential expression of TFH-related markers. TFH 
markers either were not detected or showed a non-specific scattered pattern in skin 
biopsy. Although, other authors reported that higher IL-21 mRNS expression could be 
detected in skin biopsy of AD patients, perhaps it was secreted by other sources, for 
example Th17 cells. We suppose that blood TFH cells could migrate to regional lymph 
nodes rather than traffic to the skin. This statement is consistent with a study which 
demonstrate a divergent expression design for IL-4 and IL-13 during allergic condition, 
because it state that lung CD4+ T cells do not express PD-1 and CXCR5, as well as TFH 
cells in the lymph node express significant amounts of both IL-4 and IL-21 mRNA, but 
not IL-13 [52]. Another group examined the effects of di-(2-ethylhexyl)phthalate (DEHP) 
on humoral immunity in splenocytes and found that it acts as an adjuvant to increase the 
secretion of allergy-related IgE and IgG1 as a result of the stimulation of IL-21 and IL-4 
production via the over-expression of transcription factors Bcl-6 and Maf in TFH cells 
[53]. 
In conclusion, our results revealed an expansion in the ratio and number of circulating 
TFH-like cells and IL-21 producing TFH-like cells in children with AD compared to adult 
patients, moreover a clear correlation between these elevated T cell subsets and the 
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severity of skin inflammation. However, we also have to mention some limitations of this 
study. Since AD is a clinically heterogeneous disease and we worked with a relatively 
small sample size, our results should be confirmed in an independent set of patients and 
controls as well. Nevertheless, these results reinforce the importance of further 
investigations of TFH-like cells with special attention to the interaction of B cells and 
certain TFH cell subsets in different phenotypes and endotypes of AD. 
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Tables 
 
Table 1. Demographic data of AD patients and controls enrolled in the study. 
 
Parameter 
Healthy 
controls 
(total; n=14) 
Healthy 
children 
(n=4) 
Healthy 
adults 
(n=10) 
Patients with 
AD (total; 
n=29) 
Children 
with AD 
(n=12) 
Adults with 
AD (n=17) 
Age (years)       
range 4-37 4-15 23-37 4-42 4-16 18-42 
mean ± SD 22.64 ± 10.16 8.50 ± 4.80 28.03 ± 4.14 18.97 ± 11.03 9.58 ± 3.81 26.58 ± 7.99 
Sex (no.)       
female 11 3 8 19 10 9 
male 3 1 2 10 2 8 
SCORAD score       
range    24-72 28-68 24-72 
mean ± SD    43.21 ± 13.04 
43.67 ± 
11.91 
42.88 ± 
13.82 
IgE (kU/L)       
median 
(range) 
   
1453 (22-
10000) 
637 (22-
10000) 
2537 (135-
10000) 
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Figure legends 
 
Figure 1. Comparison of the frequency of TFH-related cell markers in the CD4
+CXCR5+ 
T cell subpopulation from AD patients and healthy controls. Representative dot plots 
show the gating strategy (panels on the left), the expression of ICOS+PD-1+ cells (top 
panel on the right) and PD-1+IL-21+ cells (bottom panel on the right). (A) Percentages of 
ICOS+, PD-1+ and ICOS+PD-1+ cells in the CD4+CXCR5+ T cell subset from the two 
subgroups of AD patients (children with AD; n=12, black dots and adults with AD; n=17, 
grey dots) and healthy controls (n=14, empty dots). (B) Frequency of PD-1+, IL-21+ and 
PD-1+IL-21+ cells in the CD4+CXCR5+ T cell subset from the two subpopulations of AD 
patients and healthy donors. Each data point represents an individual subject; horizontal 
lines show the mean values with standard deviation (SD). Statistically significant 
differences are indicated by *, p < 0.05; **, p < 0.01; ns, no significant differences.  
 
Figure 2. Determination of circulating TFH-like cells in children and adults with AD 
versus healthy subjects. (A) Percentages of CD4+CXCR5+ICOS+ T cells, 
CD4+CXCR5+PD-1+ T cells and CD4+CXCR5+ICOS+PD-1+ TFH-like cells in children 
with AD (n=12, black dots), adults with AD (n=17, grey dots) and control subjects (n=14; 
empty dots). Peripheral TFH-like cells were assessed as their percentage in the CD4
+ 
lymphocyte population. (B) Absolute numbers of CD4+CXCR5+ICOS+ T cells, 
CD4+CXCR5+PD-1+ T cells and CD4+CXCR5+ICOS+PD-1+ TFH-like cells in children 
with AD (n=13, black dots), adults with AD (n=17, grey dots) and control subjects (n=11; 
empty dots). Each data point represents an individual subject; horizontal lines show the 
mean values with standard deviation (SD). Statistically significant differences are 
indicated by *, p < 0.05; **, p < 0.01; ns, no significant differences. 
29 
 
 
Figure 3. Determination of IL-21 producing circulating TFH-like cells in children and 
adults with AD versus healthy subjects. (A) Frequency of CD4+CXCR5+PD-1+ T cells, 
CD4+CXCR5+IL-21+ T cells and CD4+CXCR5+PD-1+IL-21+ TFH-like cells in patients 
with AD (children; n=12, black dots and adults; n=17, grey dots) and healthy controls 
(n=14; empty dots). (B) Absolute numbers of CD4+CXCR5+PD-1+ T cells, 
CD4+CXCR5+IL-21+ T cells and IL-21+ producing TFH-like cells in the two subgroups of 
AD patients and healthy individuals (n=11; empty dots). Each data point represents an 
individual subject; horizontal lines show the mean values with standard deviation (SD). 
Statistically significant differences are indicated by **, p < 0.01; ns, no significant 
differences. (C) Correlation between the absolute number of CD4+CXCR5+PD-1+IL-21+ 
TFH-like cells and SCORAD (SCORing Atopic Dermatitis) index. Each data point 
represents an individual subject. The regression line is shown in each panel (R, Pearson’s 
correlation coefficient; p, P-value). 
 
Figure 4. Immunohistochemical analysis of skin biopsy specimens from AD patients with 
a special emphasis on the presence and distribution of TFH-related molecules. CD3 pan-
T cell, CD20 pan-B cell and TFH-specific marker (PD-1, CD84, Bcl-6, IL-21) expression 
in lesional skin from patients with AD (n=5). Boxed areas indicate the localization of the 
zoomed-in images in the right. Scale bar on the slides are 200 μm (left images) and 50 
μm (right images). 
 
